Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 11,514 | 5,706 | 14,039 | 14,820 | 3,031 |
| Cost of Goods | 10,356 | 279 | 12,575 | 11,467 | 2,552 |
| Gross Profit | 1,159 | 5,427 | 1,465 | 3,354 | 479 |
| Operating Expenses | 969 | 8,486 | 826 | 1,754 | 812 |
| Operating Income | 545 | -2,780 | 1,213 | 2,066 | 219 |
| Other Income | -147 | 138 | -162 | -453 | -70 |
| Pre-tax Income | 399 | -2,643 | 1,051 | 1,613 | 149 |
| Income Tax | 22 | 61 | 1,432 | N/A | 0 |
| Net Income Continuous | 377 | -2,704 | -381 | 1,613 | 149 |
| Net Income | $377 | $-2,704 | $-381 | $1,613 | $149 |
| EPS Basic Total Ops | 0.01 | -0.05 | -0.01 | 0.03 | 0.00 |
| EPS Basic Continuous Ops | 0.01 | -0.05 | -0.01 | 0.03 | 0.00 |
| EPS Diluted Total Ops | 0.01 | -0.05 | -0.01 | 0.03 | 0.00 |
| EPS Diluted Continuous Ops | 0.01 | -0.05 | -0.01 | 0.03 | 0.00 |
| EBITDA(a) | $3,226 | $-2,435 | $995 | $2,613 | $301 |